PGD/PGS
Are you worried about affecting your baby with genetic disorders? Does infertility take away your peace of mind? Then you can rely on our genetic testing procedures. We at New Hope use the improved fertility methods and testing to remove the chance of gene disorder transfer.
We use Pre-implantation genetic diagnosis (PGD) or Pre-implantation Genetic Screening (PGS) to determine the presence of genetic disorder in your embryo cells. Although these two procedures are often interchangeable, their technique is somewhat different. If you are planning to undergo any fertility treatment, then you may need to undergo gene resting before egg implantation.
Who are the most suitable candidates for PGD?
Pre-implantation genetic diagnosis (PGD) is beneficial for couples who have and/or suffering from:
- Congenital diseases that are likely to pass on to their next generation
- Single gene conditions such as sickle cell anemia, cystic fibrosis, or any other disorders
- Presence of genetic history of sexual disorders like Duchenne muscular dystrophy, Fragile X syndrome, or other syndromes
Who are the right candidates for PGS?
- Couples with the risk of embryos anomalies
- Couples undergoing IVF treatment
- Couples suffering from repeated unsuccessful IVF cycles
- Women in their advanced age
- Women with an increased number of embryos
- Women dealing with multiple miscarriages
- Men dealing with severe infertility
What are the steps of conducting
Preimplantation Genetic Diagnosis or PGD?
Preimplantation Genetic Diagnosis, popular as PGD, is a method that delivers information on the genetic make-up of the cells present in a mature egg. It can detect about 2000 single-gene disorders.
- Our experts perform a biopsy of the embryo to extract around 3 to 8 cells on day 5, i.e., a blastocyst
- The cells are then sent to the laboratory for the embryologist to test
- The embryologist then analyze and evaluate how much the embryos are affected or unaffected.
What are the steps of conducting
Preimplantation Genetic Screening or PGS?
Pre-implantation Genetic Screening or PGS indicates the presence of average chromosome count, i.e., 46 chromosomes, in an embryo.
- Once the embryo develops in the laboratory, the embryologist performs embryo biopsy on day 5 when at the blastocyst stage.
- Some embryo cells are taken to determine the chromosome count within a single cell.
- If the result shows an average chromosome count, it attains a “euploid” report. In contrast to this, if the number is abnormal, then the report suggests an “aneuploid.”
- In the case of aneuploid, the experts avoid the transfer of embryo anomaly in the uterus.